Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: J Thorac Oncol. 2015 Jan;10(1):110–115. doi: 10.1097/JTO.0000000000000385

Table 5.

Proposed Prognostic Risk Groups for Platinum-Treated Small Cell Lung Cancer Patients

High Risk (2 Factors) Elevated LDH And ≥ 5% Weight Loss
Or Zubrod
Performance Status > 0
Intermediate Risk (1 Factor) Elevated LDH (& not High Risk) Or Male
Low Risk (0 Factors) Normal LDH And Female

Note: Lactate dehydrogenase (LDH) and sex were the only variables that define the intermediate and low risk categories